Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanqing Liu

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
JHEP Reports : Innovation in Hepatology|May 26, 2023
Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individualsZewen Sun, Xingchen Pan, Aowen Tian, et al.
Journal of Hepatology|October 28, 2021
Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagyXiaojuan Chao, Shaogui Wang, Sam Fulte, et al.
The American Journal of Pathology|May 11, 2025
The Patatin-Like Phospholipase Domain-Containing 3 148M Variant Exacerbates Alcohol-Induced Liver Injury and Tumorigenesis in MiceJung-Hyo Cho, Hyeong-Geug Kim, Menghao Huang, et al.
Antioxidants & Redox Signaling|March 11, 2017
Oxidized Derivatives of Linoleic Acid in Pediatric Metabolic Syndrome: Is Their Pathogenic Role Modulated by the Genetic Background and the Gut Microbiota?Domenico Tricò, Anna Di Sessa, Sonia Caprio, et al.
Cancer Chemotherapy and Pharmacology|August 5, 2008
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compoundsFederico Innocenti, Snezana Mirkov, Ramamoorthy Nagasubramanian, et al.
Aging|October 17, 2016
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humansWanqing Liu, Quentin M Anstee, Xiaoliang Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 23, 2025
Targeting polyunsaturated fatty acids desaturase FADS1 inhibits renal cancer growth via ATF3-mediated ER stress responseGioia Heravi, Zhenjie Liu, Mackenzie Herroon, et al.
Nature Communications|November 26, 2025
Wafer-scale uniform epitaxy of transferable 2D single crystals for gate-all-around nanosheet field effect transistorsChengyuan Xue, Congwei Tan, Xin Gao, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Targeting Fatty Acid Desaturase I Inhibits Renal Cancer Growth Via ATF3-mediated ER Stress ResponseGioia Heravi, Zhenjie Liu, Mackenzie Herroon, et al.
Pharmacogenetics and Genomics|December 5, 2013
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469Jacqueline Ramírez, Tae Won Kim, Wanqing Liu, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
JHEP Reports : Innovation in Hepatology|May 26, 2023
Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individualsZewen Sun, Xingchen Pan, Aowen Tian, et al.
Journal of Hepatology|October 28, 2021
Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagyXiaojuan Chao, Shaogui Wang, Sam Fulte, et al.
The American Journal of Pathology|May 11, 2025
The Patatin-Like Phospholipase Domain-Containing 3 148M Variant Exacerbates Alcohol-Induced Liver Injury and Tumorigenesis in MiceJung-Hyo Cho, Hyeong-Geug Kim, Menghao Huang, et al.
Antioxidants & Redox Signaling|March 11, 2017
Oxidized Derivatives of Linoleic Acid in Pediatric Metabolic Syndrome: Is Their Pathogenic Role Modulated by the Genetic Background and the Gut Microbiota?Domenico Tricò, Anna Di Sessa, Sonia Caprio, et al.
Cancer Chemotherapy and Pharmacology|August 5, 2008
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compoundsFederico Innocenti, Snezana Mirkov, Ramamoorthy Nagasubramanian, et al.
Aging|October 17, 2016
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humansWanqing Liu, Quentin M Anstee, Xiaoliang Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 23, 2025
Targeting polyunsaturated fatty acids desaturase FADS1 inhibits renal cancer growth via ATF3-mediated ER stress responseGioia Heravi, Zhenjie Liu, Mackenzie Herroon, et al.
Nature Communications|November 26, 2025
Wafer-scale uniform epitaxy of transferable 2D single crystals for gate-all-around nanosheet field effect transistorsChengyuan Xue, Congwei Tan, Xin Gao, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Targeting Fatty Acid Desaturase I Inhibits Renal Cancer Growth Via ATF3-mediated ER Stress ResponseGioia Heravi, Zhenjie Liu, Mackenzie Herroon, et al.
Pharmacogenetics and Genomics|December 5, 2013
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469Jacqueline Ramírez, Tae Won Kim, Wanqing Liu, et al.
Pageof 17